benzofuran-2-sulphinic acid | 126714-88-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: benzofuran-2-sulphinic acid
• 英文别名: 1-Benzofuran-2-sulfinic acid
• CAS: 126714-88-3
• 化学式: C₈H₆O₃S
• 分子量: 182.2
• InChiKey: NEYNTOLNQXXOAT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  69.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Heterocyclic nitromethane derivatives
  申请人：IMPERIAL CHEMICAL INDUSTRIES PLC

  公开号：EP0340010A2

  公开（公告）日：1989-11-02

  The invention concerns novel heterocyclic nitromethane derivatives of the formula 1 as defined hereinafter (and their non-­toxic salts) wherein the heterocyclic moiety Q may bear a wide variety of optional substituents, together with pharmaceutical compositions containing them. The nitromethane derivatives are inhibitors of the enzyme aldose reductase and are of value in the treatment of certain complications of diabetes and galactosemia. The invention further concerns novel processes for the manufacture and use of said inhibitors.

  本发明涉及下文定义的式 1 的新型杂环硝基甲烷衍生物（及其无毒盐类），其中杂环分子 Q 可带有多种任选取代基，以及含有这些衍生物的药物组合物。硝基甲烷衍生物是醛糖还原酶的抑制剂，对治疗糖尿病和半乳糖血症的某些并发症具有重要价值。本发明还涉及制造和使用上述抑制剂的新工艺。
• NOVEL 1,2-BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
  申请人：ALLERGAN, INC.

  公开号：EP2955173A1

  公开（公告）日：2015-12-16

  The present invention relates to novel bis-sulfonamide derivatives of Formula I, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.

  本发明涉及式 I 的新型双磺酰胺衍生物、其制备工艺、含有它们的药物组合物以及它们作为趋化因子受体调节剂的药物用途。
• HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME
  申请人：EA Pharma Co., Ltd.

  公开号：EP3101015A1

  公开（公告）日：2016-12-07

  The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof. The compound has a superior TRPA1 antagonist activity, and can provide a medicament useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.

  本发明提供了一种由式 (I) 表示的化合物： 其中各符号如说明书中所定义、 或其药学上可接受的盐。该化合物具有优异的 TRPA1 拮抗剂活性，可提供一种用于预防或治疗涉及 TRPA1 拮抗剂和 TRPA1 的疾病的药物。
• LIGHT EMITTING DEVICE AND FLUORESCENT MATERIAL
  申请人：Murayama Tetsuo

  公开号：US20070085057A1

  公开（公告）日：2007-04-19

  The present invention is to provide a light emitting device which can generate high-intensity light emission, using a fluorescent material containing a rare earth element ion complex and being excellent in durability and also provide the fluorescent material to be used therein. The present invention relates to a light emitting device comprising a semiconductor light emitting element which emits light within the region from near-ultraviolet light to visible light, and a fluorescent material which contains a rare earth element ion complex having an aromatic ring-containing Bronsted acid ion with a pKa value of 7 or less as a ligand and emits light by the action of light of the semiconductor light emitting element.
• US5102905A
  申请人：——

  公开号：US5102905A

  公开（公告）日：1992-04-07